CD8A and neoplasm: By contrast, among patients with metastatic melanoma, ACT responders displayed higher levels of checkpoint receptors; the expression patterns of PD-1, LAG-3, and TIM-3 may serve as markers for CD8+ tumor-reactive T-cell populations within the TIL pool (181).